Lung Cancer Clinical Trial

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

Summary

This study is for patients with advanced non small cell lung cancer that has progressed despite standard of care. The purpose of the study is to see if Kanglaite injection has any effect on survival.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

confirmed (within last 3 months)progressive Stage IV NSCLC
estimated life span of 3 months
phase angle of at least 5 as measured by bioimpedance

Exclusion Criteria:

currently taking a lipid lowering medications
has an imminently life threatening condition
has pre-existing liver disease
known allergy to soybeans
uncontrolled diabetes or uncontrolled disturbance of lipid metabolism
pregnant or lactating
has a pacemaker or other implantable electronic medical device

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

1

Study ID:

NCT01640730

Recruitment Status:

Terminated

Sponsor:

KangLaiTe USA

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

The West Clinic
Memphis Tennessee, 38120, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

1

Study ID:

NCT01640730

Recruitment Status:

Terminated

Sponsor:


KangLaiTe USA

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider